HilleVax, Inc.
HLVX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $99,727 | $72,472 | $102,638 | $86,913 |
| - Cash | $58,677 | $47,485 | $154,467 | $103,764 |
| + Debt | $23,542 | $24,039 | $24,513 | $24,973 |
| Enterprise Value | $64,592 | $49,026 | -$27,316 | $8,122 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,788 | -$5,571 | -$33,093 | -$23,128 |
| % Margin | – | – | – | – |
| Net Income | -$5,266 | -$6,061 | -$33,947 | -$25,823 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.11 | -0.12 | -0.68 | -0.52 |
| % Growth | 8.3% | 82.4% | -30.8% | – |
| Operating Cash Flow | -$789 | -$12,718 | -$18,188 | -$27,822 |
| Capital Expenditures | $0 | $0 | -$110 | -$1,712 |
| Free Cash Flow | -$789 | -$12,718 | -$18,298 | -$29,534 |